Biosimilars Explainer Animations
The U.S. Food and Drug Administration (FDA) tasked my team and me with creating a series of animated videos explaining the complex topic of biosimilar products to medical professionals.
This was an exciting task for us to take on because it offered a chance to move FDA from more traditional talking head videos and very literal animations to the abstract with a modern art style and motion design. My colleague, Jasmina Mann, created the art; our art director, Maureen Berg led the overall design; and I helped write the scripts and concept visuals. I took it from there through completion with animatics, full animation, lighting effects, and the audio mix.
Summarizing the topic of biosimilars was no easy task. We worked hard on the scripts to balance important scientific information with the informative and easy-to-understand style that an explainer video offers.
Next, my team and I spent a lot of time concepting visuals that paired well with our scripts but weren't too literal. The decision to lean more into abstract visuals was twofold: First, some of the scientific concepts, such as interchangeability, are so complex that only data can explain them; they have no accompanying visual. Second, we were very excited to try something new with FDA, and they were on board, as well. There was a leap of faith on their part in trusting that we could provide a new type visual that diverged significantly from their previous communications.
In the end, our efforts paid off and our clients were very happy and impressed with the final results. We were even asked to update another project to more closely match this modern, abstract style.